Key facts
- Notable investors include Shanghai Rui Investment Fund Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Mizhiyuan
- ·The full record, as it builds
Funding rounds
No funding rounds for Mizhiyuan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mizhiyuan
Operator of a biopharmaceutical platform based in Wenzhou, China. The company focuses on the research and application of exosomes and cell medicine.
- Sector
- Healthcare
- HQ
- Wenzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Mizhiyuan doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mizhiyuan shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mizhiyuan in its N-PORT filings yet. We sweep new filings monthly.